清醒男性中丹曲林的剂量反应：对恶性高热治疗的启示 - Suppr

Suppr

超能文献

Dantrolene dose response in awake man: implications for management of malignant hyperthermia.

作者信息

Flewellen E H, Nelson T E, Jones W P, Arens J F, Wagner D L

出版信息

Anesthesiology. 1983 Oct;59(4):275-80. doi: 10.1097/00000542-198310000-00002.

DOI:10.1097/00000542-198310000-00002

PMID:6614536

Abstract

摘要

相似文献

Dantrolene dose response in awake man: implications for management of malignant hyperthermia.

Anesthesiology. 1983 Oct;59(4):275-80. doi: 10.1097/00000542-198310000-00002.

Dantrolene. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in malignant hyperthermia, the neuroleptic malignant syndrome and an update of its use in muscle spasticity.

Drugs. 1986 Aug;32(2):130-68. doi: 10.2165/00003495-198632020-00003.

[Sodium dantrolene].

Rev Esp Anestesiol Reanim. 1985 Jul-Aug;32(4):179-83.

Comparison of the therapeutic effectiveness of a dantrolene sodium solution and a novel nanocrystalline suspension of dantrolene sodium in malignant hyperthermia normal and susceptible pigs.

Eur J Anaesthesiol. 2011 Apr;28(4):256-64.

Effects of azumolene on normal and malignant hyperthermia-susceptible skeletal muscle.

Basic Clin Pharmacol Toxicol. 2008 Mar;102(3):308-16. doi: 10.1111/j.1742-7843.2007.00156.x. Epub 2007 Nov 28.

Dantrolene and "ecstasy".

Med J Aust. 1997 Feb 3;166(3):165-6. doi: 10.5694/j.1326-5377.1997.tb140056.x.

Rationale for dantrolene vs. procainamide for treatment of malignant hyperthermia.

Anesthesiology. 1979 Feb;50(2):118-22. doi: 10.1097/00000542-197902000-00008.

Drug treatment of malignant hyperpyrexia.

Anaesth Intensive Care. 1977 Aug;5(3):207-13. doi: 10.1177/0310057X7700500303.

Human malignant hyperthermia: awake episodes and correction by dantrolene.

Anesth Analg. 1980 May;59(5):377-8.

Malignant hyperthermia: presymptomatic screening and treatment 2011.

Eur J Anaesthesiol. 2011 Apr;28(4):237-9. doi: 10.1097/EJA.0b013e3283433b9f.

引用本文的文献

Management of Suspected Malignant Hyperthermia With Dantrolene: Clinical Insights From 2 Case Reports in a Single-Center Experience.

Clin Med Insights Case Rep. 2025 Jun 14;18:11795476251349345. doi: 10.1177/11795476251349345. eCollection 2025.

Development of Ryanodine Receptor (RyR) Inhibitors for Skeletal Muscle and Heart Diseases.

Juntendo Iji Zasshi. 2023 Apr 26;69(3):180-187. doi: 10.14789/jmj.JMJ22-0045-R. eCollection 2023.

Current clinical application of dantrolene sodium.

Anesth Pain Med (Seoul). 2023 Jul;18(3):220-232. doi: 10.17085/apm.22260. Epub 2023 Jul 26.

Function of a mutant ryanodine receptor (T4709M) linked to congenital myopathy.

Sci Rep. 2023 Sep 5;13(1):14659. doi: 10.1038/s41598-023-41801-2.

Molecular Aspects Implicated in Dantrolene Selectivity with Respect to Ryanodine Receptor Isoforms.

Int J Mol Sci. 2023 Mar 12;24(6):5409. doi: 10.3390/ijms24065409.

Chronic Elevation of Skeletal Muscle [Ca] Impairs Glucose Uptake. An and Study.

Front Physiol. 2022 Apr 25;13:872624. doi: 10.3389/fphys.2022.872624. eCollection 2022.

Modulation of Ryanodine Receptors Activity Alters the Course of Experimental Autoimmune Encephalomyelitis in Mice.

Front Physiol. 2021 Dec 17;12:770820. doi: 10.3389/fphys.2021.770820. eCollection 2021.

Dantrolene Prevents the Lymphostasis Caused by Doxorubicin in the Rat Mesenteric Circulation.

Front Pharmacol. 2021 Aug 16;12:727526. doi: 10.3389/fphar.2021.727526. eCollection 2021.

A novel RyR1-selective inhibitor prevents and rescues sudden death in mouse models of malignant hyperthermia and heat stroke.

Nat Commun. 2021 Jul 13;12(1):4293. doi: 10.1038/s41467-021-24644-1.

A target-agnostic screen identifies approved drugs to stabilize the endoplasmic reticulum-resident proteome.

Cell Rep. 2021 Apr 27;35(4):109040. doi: 10.1016/j.celrep.2021.109040.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验